Christopher Tarnay
University of California, Los Angeles
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Christopher Tarnay.
Obstetrics & Gynecology | 2014
Jennifer T. Anger; Elizabeth R. Mueller; Christopher Tarnay; Bridget Smith; Kevin T. Stroupe; Amy Rosenman; Linda Brubaker; Catherine Bresee; Kimberly Kenton
OBJECTIVE: Laparoscopic and robotic sacrocolpopexy are widely used for pelvic organ prolapse (POP) treatment. Evidence comparing outcomes and costs is lacking. We compared costs and clinically relevant outcomes in women randomized to laparoscopic sacrocolpopexy compared with robotic sacrocolpopexy. METHODS: Participants with symptomatic stage POP II or greater, including significant apical support loss, were randomized to either laparoscopic or robotic sacrocolpopexy. We compared surgical costs (including costs for robot, initial hospitalization) and rehospitalization within 6 weeks. Secondary outcomes included postoperative pain, POP quantification, symptom severity and quality of life, and adverse events. RESULTS: We randomized 78 women (mean age 59 years): laparoscopic (n=38) and robotic (n=40). The robotic sacrocolpopexy group had higher initial hospital costs (
Obstetrics & Gynecology | 1999
Christopher Tarnay; Karen B. Glass; Malcolm G. Munro
19,616 compared with
Obstetrics & Gynecology | 1999
Christopher Tarnay; Karen B. Glass; Malcolm G. Munro
11,573, P<.001) and over 6 weeks, hospital costs remained higher for robotic sacrocolpopexy (
Female pelvic medicine & reconstructive surgery | 2012
Jennifer T. Anger; Una J. Lee; Brita Mittal; Matthew E. Pollard; Christopher Tarnay; Sally L. Maliski; Rebecca G. Rogers
20,898 compared with
Female pelvic medicine & reconstructive surgery | 2013
Marianna Alperin; Aqsa Khan; Emily Dubina; Christopher Tarnay; Ning Wu; Chris L. Pashos; Jennifer T. Anger
12,170, P<.001). When we excluded costs of robot purchase and maintenance, we did not detect a statistical difference in initial day of surgery costs of robotic compared with laparoscopic (
Contemporary Clinical Trials | 2012
Elizabeth R. Mueller; Kim Kenton; Christopher Tarnay; Linda Brubaker; Amy Rosenman; Bridget Smith; Kevin T. Stroupe; Catherine Bresee; A. Pantuck; P. Schulam; Jennifer T. Anger
12,586 compared with
Annals of Surgery | 2015
Stacey C. Carter; Alexander Chiang; Galaxy Shah; Lorna Kwan; Jeffrey S. Montgomery; Amer Karam; Christopher Tarnay; Khurshid A. Guru; Jim C. Hu
11,573; P=.160) or hospital costs over 6 weeks (
Journal of The American Association of Gynecologic Laparoscopists | 1999
Karen B. Glass; Christopher Tarnay; Malcolm G. Munro
13,867 compared with
Obstetrics & Gynecology | 2004
Malcolm G. Munro; Christopher Tarnay
12,170; P=.060). The robotic group had longer operating room times (202.8 minutes compared with 178.4 minutes, P=.030) and higher pain scores 1 week after surgery (3.5±2.1 compared with 2.6±2.2; P=.044). There were no group differences in symptom bother by Pelvic Floor Distress Inventory, POP stage, or rate of adverse events. CONCLUSION: Costs of robotic sacrocolpopexy are higher than laparoscopic, whereas short-term outcomes and complications are similar. Primary cost differences resulted from robot maintenance and purchase costs. CLINICAL TRIAL REGISTRATION: Clinicaltrials.gov, www.clinicaltrials.gov, NCT01124916. LEVEL OF EVIDENCE: I
Journal of The American Association of Gynecologic Laparoscopists | 2003
Karen B. Glass; Christopher Tarnay; Malcolm G. Munro
OBJECTIVE Laparoscopic trocar-cannula systems of different design but similar internal diameter result in incisions of varying dimensions. Such variations might affect the incidence of incisional complications, such as dehiscence and hernia. We developed a system to measure associated fascial defects and then used the techniques to compare the defects resulting from different trocar-cannula systems. METHODS This was a randomized, observer-blinded study. Six laparoscopic trocar-cannula systems of similar diameter (12 mm) were tested (two pyramidal, two blunt conical, and two cutting-dilating) using a white swine model. All systems were inserted into each of 12 subjects, with location designated by random allotment (total 72 insertions). The fascial defects were exposed and then directly measured for incisional length and area by an observer blinded to the system used. Means of each outcome variable (incisional length and area) were compared using factorial analysis of variance. RESULTS The values for mean incisional areas were as follows: cutting-dilating 28.73 mm2 and 31.09 mm2, pyramidal 18.25 mm2 and 26.75 mm2, and blunt conical 10.00 mm2 and 12.33 mm2. Mean maximal incisional lengths were similar among all trocar-cannula systems. CONCLUSION Blunt conical trocar-cannula systems resulted in significantly smaller fascial defects compared with the widely used pyramidal and the two cutting-dilating trocar-cannula systems tested. These differences have potential clinical implications. For example, smaller fascial defects could reduce risk of incisional hernia and dehiscence.